Latest Series A Funding Rounds
Companies raising their first major institutional growth round, from the product they sell to the investors backing their next stage.
- Rounds
- 878 All time
- Disclosed funding
- $34.1B 792 disclosed amounts
- Median round
- $20M Of disclosed amounts
| Company | Amount | Round | Sector | Country | Investors | Announced |
|---|---|---|---|---|---|---|
| AT AirNexis TherapeuticsCompany profile AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. AirNexis Therapeutics develops medicines for pulmonary diseases, led by the investigational COPD candidate AN01. | $200M | Series A | Biotech | United States | Investors | |
| P ProtegeCompany profile Provides AI data platform unlocking access to trusted real-world data at scale Provides AI data platform unlocking access to trusted real-world data at scale | $30M | Series A | AI | United States | Investors | |
| VE Valinor EnterprisesCompany profile Builds and buys critical defense and government technology solutions Builds and buys critical defense and government technology solutions | $54M | Series A | Defense tech | United States | Investors | |
| T TucuviCompany profile Tucuvi provides conversational AI for clinical patient follow-up and monitoring. Tucuvi provides conversational AI for clinical patient follow-up and monitoring. | $20M | Series A | AI | Spain | Investors | |
| SA Spangle AICompany profile Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce Builds agentic infrastructure layer connecting AI-led discovery to real-time conversion for commerce | $15M | Series A | AI | United States | Investors | |
| ED Enhanced Digital Group Inc.Company profile Provides derivatives solutions in the digital asset space for institutional clients Provides derivatives solutions in the digital asset space for institutional clients | Undisclosed | Series A | Fintech | United States | Investors | |
| V Builds technologies for spatial biology and multi-omics innovation | $48M | Series A | Biotech | United States | Investors | |
| B BrightHeartCompany profile BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. BrightHeart develops AI software for prenatal ultrasound and fetal-heart screening. | €11M | Series A | AI | France | Investors | |
| PT Poplar TherapeuticsCompany profile Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions Developing a new class of anti-IgE therapy to treat food allergy and other atopic conditions | $50M | Series A | Healthtech | United States | Investors | |
| PS Provides AI-native due diligence for life sciences dealmaking | $20M | Series A | Biotech | United States | Investors |
Active investors in this selection
All investors →Ranked by rounds participated in · All time
- 1Y Combinator (YC)
Clueso, Santé, Flai
52rounds0led - 2Andreessen Horowitz (a16z)
Eka Robotics, TypeSafe AI, Sharp Performance
29rounds9led - 3General Catalyst
Baba, Melius, Disha (formerly Curelink)
24rounds1led - 4Lightspeed
Warp Sciences, Zenzap, Avarra
21rounds4led - 5Alumni Ventures
Chariot Claims, RegCell, Inc., Lightfield
21rounds0led
Latest digests
Archive →Explore published rounds while the next edition is being prepared.